Arkolith/Insider Trading/AXSM/Form 4

Tabuteau Herriot

Chief Executive Officer, Director, 10% OwnerAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Feb 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.0M
Net Open-Market Flow
-$6.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Sell(S)32K$185.60$6.0M7K
Feb 2, 2026Option exercise(M)32K$8.02$260K40K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 2, 2026Option exercise(M)32K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-033973) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML